Dr. Farmakiotis is the Director of Transplant and Oncology Infectious Diseases (ID) at Rhode Island Hospital, the Lifespan Cancer Center and Cardiovascular Institute (heart transplant and VAD ID clinic). He also attends on the teaching general ID service. Dr. Farmakiotis graduated valedictorian from the Aristotle University of Thessaloniki, Greece, and trained in Internal Medicine at Albert Einstein College of Medicine/Jacobi Medical Center in the Bronx, NY. He completed his ID fellowship at Baylor College of Medicine on the MD Anderson Immunocompromised Host Track, in Houston, TX, and served as Chief Fellow for Baylor ID, followed by one year of advanced training in Transplant-Oncology ID at Brigham and Women's Hospital and the Dana-Farber Cancer Institute of Harvard Medical School. Dr. Farmakiotis' clinical and research interests focus on common and opportunistic infections in immunocompromised patients, particularly invasive fungal infections, mechanisms and clinical significance of resistance to antifungals in Candida species, antifungal stewardship, VAD infections, CMV, HIV and hepatitis-C in transplantation, and COVID-19.